Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy (Q68871483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

R T Chlebowski

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J M Weiner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

R Reynolds

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J Luce

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

L Bulcavage

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J R Bateman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

23-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project

28 September 2019

cites work

1 reference

12 December 2020

Combined modality approach in breast cancer with isolated or multiple metastases

1 reference

12 December 2020

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

12 December 2020

Disease-free survival at intervals during and following completion of adjuvant chemotherapy: the NSABP experience from three breast cancer protocols

1 reference

12 December 2020

Status of adjuvant chemotherapy in patients with breast cancer

1 reference

12 December 2020

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

12 December 2020

Breast cancer and weight gain: an unexpected finding

1 reference

12 December 2020

Treatment of advanced breast carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery

1 reference

12 December 2020

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

1 reference

12 December 2020

L-phenylalanine mustard (L-PAM) in the management of primary breast cancer:An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)

1 reference

12 December 2020

Adjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast

1 reference

12 December 2020

Weight gain during adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Nonobesity at the time of mastectomy is highly predictive of 10-year disease-free survival in women with breast cancer

1 reference

12 December 2020

Weight loss during therapy for advanced breast cancer.

1 reference

12 December 2020

Body weight and prognosis in breast cancer.

1 reference

12 December 2020

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

12 December 2020

Height, weight, and risk of breast cancer relapse

1 reference

12 December 2020

The association of body weight with recurrent cancer of the breast

1 reference

12 December 2020

Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes

1 reference

12 December 2020

Symptomatology as an indicator of recurrent or metastatic breast cancer

1 reference

12 December 2020

Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy

1 reference

12 December 2020

Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation

1 reference

12 December 2020

Cholesterol and obesity as prognostic factors in breast cancer

1 reference

12 December 2020

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer

1 reference

12 December 2020

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCER

1 reference

12 December 2020

Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01886732

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516262%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference